Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute pouchitis assessment during standard-of-care antibiotic treatment
NL-OMON54456Active, not recruiting
- Sponsor
- Alimentiv Inc.
- Start
- Aug 2022
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ciprofloxacin, metronidazole and amoxicillin + clavulanate in pouchitis and Acute pouchitis, sponsored by Alimentiv Inc. Primary endpoints: Reliability and responsiveness of endoscopic items, Reliability and responsiveness of histologic items and 3 more. Started Aug 2022; status: active, not recruiting.
02
Drugs
ciprofloxacinmetronidazoleamoxicillin + clavulanate
03
Conditions
pouchitisAcute pouchitis
Beyond the preview
Go deeper on NL-OMON54456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54456.